Dendreon Corporation Implements Oracle(R) E-Business Suite Applications To Manage Corporate And Clinical Information

REDWOOD SHORES, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Oracle today announced that Dendreon Corporation , a Seattle-based biotechnology company that develops innovative therapeutics that harness the immune system to fight cancer, has implemented the Oracle(R) E-Business Suite to help it manage the manufacture and distribution of patient-specific cancer treatments in its clinical trials, document regulatory compliance and ensure the security of patient data.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020718/ORCLLOGO )

Dendreon selected applications from the Oracle E-Business Suite, including Oracle Order Management, Oracle Process Manufacturing and Oracle Advanced Supply Chain Planning, to streamline logistics and manufacturing processes and help ensure that its active immunotherapy product candidate, PROVENGE(R) (sipuleucel-T), is processed efficiently and cost effectively. PROVENGE is a first-in-class product currently under investigation that is designed to use the patient's own immune system to fight cancer. Dendreon plans to submit an application to the U.S. Food and Drug Administration later this year to obtain approval to market PROVENGE.

"In planning our commercial strategy, we recognized the need to automate to meet our expanding business and regulatory requirements. Oracle understands our business and the intricacies of the biotech industry -- making it the clear choice over other vendors," said Linda Staley, Dendreon Corporation's Vice President of Information Technology. "With Oracle applications, we can support our clinical processes and prepare for future anticipated commercial needs, providing us with the ability to reliably introduce our innovative products."

It is important that Dendreon know exactly where each patient-specific treatment is in the supply chain at any given time to ensure quality and prompt delivery. Oracle E-Business Suite enables such visibility.

The Oracle system has the ability to document the entire procurement, manufacturing and distribution process, providing important data required for compliance with U.S. Food & Drug Administration (FDA) regulations. It will help Dendreon secure patient privacy and enable creation of a secure chain from order placement through manufacturing to patient billing.

Dendreon has also implemented Oracle Financials and Oracle iProcurement to create an integrated and secure financial management system that enables real-time visibility of critical business data and automated purchasing processes.

About Oracle

Oracle is the world's largest enterprise software company. For more information about Oracle, visit our Web site at http://www.oracle.com.

Trademarks

Oracle, JD Edwards, PeopleSoft, and Siebel are registered trademarks of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.

CONTACT: Katie Barron of Oracle, +1-703-364-2488, orKatie.barron@oracle.com; or Mary Tobin of O'Keeffe & Company,+1-503-658-7396, or mtobin@okco.com

Web site: http://www.oracle.com//